Skip to main content

Table 1 The characteristics of SCLC patients and healthy controls

From: Prognostic significance of serum osteopontin levels in small cell lung cancer

Variables SCLC patients Healthy controls P
Number of subject 96 60  
Median (range) 55 (36–75) 56 (38–74) 0.618
Male/Female 66/30 40/20 0.786
Smoking history
 Ever smoker 58 32 0.384
 Never smoker 38 28  
Performance status
 0–1 56   
 2–3 40   
Disease stage
 Limited 28   
 Extended 58   
Tumor size (cm)
  ≥ 3 76   
  < 3 20   
Lymph node metastasis
 N0 26   
 N1–3 70   
Chemotherapy
 EP 80   
 EC 16   
Radiotherapy sequence
 Concurrent 43   
 After-chemotherapy 40   
 None 13   
Responses
 CR + PR 78   
 SD + PD 18   
  1. EP, etoposide+platinum; EC, etoposide+cisplatin; CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease